Working… Menu

German Observational Multicenter Study of Patients With Fabry Disease Under Chaperone Therapy With Migalastat-HCl.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03135197
Recruitment Status : Active, not recruiting
First Posted : May 1, 2017
Last Update Posted : October 7, 2019
Amicus Therapeutics
Information provided by (Responsible Party):
University Hospital Muenster

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : July 2020
Estimated Study Completion Date : July 2020